Background. Crystal retention in the kidney is caused by the interaction between crystals and the cells lining the renal tubules. These interactions involve crystal attachment, followed by internalization or not. Here, we studied the ability of various renal tubular cell lines to internalize calcium oxalate monohydrate (COM) crystals.
ally starts already in the nephrons. Crystals are frequently precipitated in the renal tubular fluid of stoneforming as well as non-stone-forming individuals [1] . Following their formation in the nephron, the crystals are rapidly covered with inhibitors of crystallization, which facilitates their excretion [2] . This elimination process is thwarted, however, when the crystals adhere to the tubular lining [3] . Several investigators in the past have proposed the concept that the onset of nephrolithiasis lies within the nephron. More than 30 years ago, Malek and Boyce [4] collected renal biopsies from idiopathic calcium oxalate stone formers who underwent nephrolithotomy, and from patients who were operated for other renal disorders. They found microliths lying in nephrons of all stone formers, whereas intranephronic calculosis, as this phenomenon was called, was observed in only a minority of the non-stone formers. Later, Hering et al [5] found microliths inside the renal collecting ducts of stone formers who required nephrectomy. More recently, Lieske et al [6] not only found intranephronic crystals in renal biopsies of a patient with type I primary hyperoxaluria, but strikingly they also found crystals inside renal tubular cells. Cell culture studies subsequently showed that calcium oxalate monohydrate (COM) crystals were taken up by renal tubular cells, and that this process stimulated cell proliferation [7, 8] . On the basis of these results, the authors proposed that this response of renal cells to crystals could play a role in the development of kidney stones. Although we extensively studied the adherence of COM crystals to renal tubule epithelial cells in culture, crystal uptake received little attention. The polysaccharide hyaluronan (HA) was identified as a major crystal-binding molecule at the surface of MadinDarby canine kidney (MDCK) strain I cells in locomotion, whereas HA-negative quiescent cells in confluent cultures are nonadherent [9] . The level of crystal binding to rat cortical collecting duct (RCCD 1 ) cells also significantly decreased during their growth to confluence (unpublished observations). Crystal binding to porcine kidney (LLC-PK 1 ) and Madin-Darby canine kidney II (MDCK-II) cells is quite different because, irrespective of their stage of development, these cells constitutively express crystalbinding molecules [10] . The present investigation was conducted to study the ability of various cell types to internalize calcium oxalate crystals.
METHODS

Cell culture
MDCK-I and MDCK-II cells [11] were kindly provided by Prof. G. van Meer (Laboratory for Cell Biology and Histology, Amsterdam Medical Center, The Netherlands). LLC-PK 1 cells were obtained from the American Type Culture Collection (ATCC). Routinely, the cells were grown in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Grand Island, NY, USA) supplemented with 10% fetal calf serum (FCS) (PAA Labs, Linz, Austria) and replated weekly. RCCD 1 cells [12] were kindly provided by Dr. M. Blot-Chabaud (INSERM U246, Faculté de Mé decine Xavier Bichat, Paris, France). Routinely, these cells were grown in DMEM/F12 supplemented with 14 mmol/L NaHCO 3 , 2 mmol/L glutamine, 5 g/mL transferrin, 5 g/mL insulin, 1.3 ng/mL sodium selenite, 10 g/mL epidermal growth factor (EGF), 5 ϫ 10 Ϫ8 mmol/L T 3 , 10 U/mL penicillin-streptomycin, and 2% FCS in collagen-coated flasks (collagen-G; 100 g/mL, Biochrom KG, Berlin, Germany) and replated weekly. Most studies described in the present investigation were obtained using subconfluent cultures. The rationale to use subconfluent cultures was that crystals do not adhere to collecting duct cells populating confluent cultures, which makes it impossible to study crystal binding and uptake at that stage of epithelial development. To obtain subconfluent cultures, cells were seeded at a plating density of 1 ϫ 10 6 cells on 24 mm polycarbonate porous filter inserts (Corning Costar, Badhoevedorp, The Netherlands). RCCD 1 cells were grown on collagen-coated inserts. Two days postseeding, the inserts contain on average 1 to 2 ϫ 10 6 cells. We considered these cultures subconfluent as it takes a few more days before the maximal amount of cells per insert (3 to 4 ϫ 10 6 cells) and the maximal transepithelial electrical resistances (TER) are reached [11, 12] . Routinely, polymerase chain reaction (PCR) analyses were performed on DNA isolated from cell culture-conditioned medium for the presence of mycoplasma. Cells used in this study were not contaminated with mycoplasma.
Crystal formation
A solution of sodium oxalate was prepared by adding 10 L 37 MBq/mL [ 
Phase-contrast microscopy
Twenty-four hours postseeding on solid growth substrates, crystals were added to proliferating small islands of cells and allowed to adhere for 30 minutes, after which all nonadhered crystals were removed and the cell surface-associated crystals inspected (magnification, ϫ200) under a phase-contrast microscope (Axiovert 25) coupled with an AxioCam camera scanner (Carl Zeiss Vision GmbH, Munchen-Hallbergmoos, Germany).
Scanning electron microscopy
Cells cultured on porous supports were fixed in 2.5% glutaraldehyde in 0.15 mol/L cacodylate buffer for 4 hours. After washing in 0.1 mol/L cacodylate buffer for 3 hours, the samples were postfixed in OsO 4 in 0.1 mol/L cacodylate buffer for 4 hours, washed again in cacodylate buffer for 3 hours, dehydrated in a graded series of ethanol, and finally critical point dried. After mounting on stubs, a conductive layer was sputter coated on the samples and examined in a Philips SEM 525 (Philips, Eindhoven, The Netherlands) (magnification, ϫ20,000).
Transmission electron microscopy
Cells were fixed in 1.5% (vol/vol) glutaraldehyde in 0.1 mol/L of cacodylate/HCl buffer for 1 hour at 37ЊC. After aldehyde fixation, cells were postfixed in 1% (weight/vol) OsO 4 in the same buffer system, to which K 4 Fe(CN 6 ).3H 2 O was added to a final concentration of 0.05 mol/L for 1 hour at room temperature. The cells were routinely dehydrated and embedded in Epon. Ultrathin sections (30 to 50 nm) were sectioned with diamond knives, collected on unfilmed 400 mesh copper grids, and inspected in a Zeiss EM 902 transmission electron microscope (Zeiss, Oberkochen, Germany) operating at 80 kV (magnification, ϫ2500).
Crystal binding
Radiolabeled crystals were added to the cultures and allowed to adhere for 1 hour, after which the inserts were extensively rinsed to remove all nonassociated crystals, cut out, and counted in a liquid scintillation counter (Packard, Meriden, CT, USA). The number of associated crystals was calculated from the disintegrations per minute (dpm)/filter [9] . The effect of hyaluronan removal on crystal-cell association was studied by treating the monolayers with 5 U/mL Streptomyces hyaluronidase (E.C. 3.2.1.35; Sigma-Aldrich Chemie, Zwijndrecht, The Netherlands) in serum-free DMEM, pH 5.3 at 37ЊC for 1 hour before the addition of radiolabeled crystals. Then crystal-binding measurements were performed as described above. Experiments were performed to examine the firmness of crystal binding. Cultures were incubated with [ 14 C] COM crystals for 1 hour. After removal of nonadhered crystals by extensive washings, the cells were treated for 10 minutes with either 70% ethanol or with a mixture of 3.7% formaldehyde/0.1% glutaraldehyde. Released crystals were removed, the inserts cut out, and the remaining cell-associated radioactivity counted. All [ 14 C]COM binding experiments were repeated at least three times, using three independent inserts per group.
Confocal laser scanning microscopy
A combination of light reflection (to visualize the crystals) and fluorescent-labeled phalloidin (to visualize the cells) was used to monitor the fate of cell-associated crystals by confocal microscopy. In time-lapse studies, nonradiolabeled COM crystals were incubated with subconfluent cultures for the indicated periods of time at 37ЊC and 4ЊC. All nonattached crystals were removed by extensive washings and the cells were fixed for 10 minutes with formaldehyde (3.7%), followed by membrane permeabilization with 70% ethanol for 10 minutes. The inserts were then washed, cut out, and incubated for 15 minutes with 2 g/mL fluorescein isothiocyanateconjugated (FITC) phalloidin (Sigma-Aldrich Chemie), washed two times with phosphate-buffered saline (PBS), and mounted in Vectashield (Vector Laboratories, Burlingame, CA, USA). A 488 nm argon laser was used to excite the FITC-phalloidin. The extra-and/or intracellular localization of the crystals was detected by 633 nm (red) Kr-laser light reflection. A 560 nm beam splitter separated the FITC emission signal and the 633 nm signal reflected by the crystals. The FITC signal was passed through a 510 to 540 nm band-pass filter to block the reflection from the 488 nm laser. No blocking filter was used for the light reflection signal. The mounted inserts were extensively inspected and images (magnification, ϫ63) were made of at least 10 random fields per insert with a Zeiss LSM 410 laser scanning confocal microscope (Zeiss), from which representative images were selected. Experiments were repeated at least three times.
Quantification of crystal internalization
To assess if cell surface-associated crystals could be internalized, [ 14 C]COM crystals were added and incubated for the indicated periods of time, after which all nonadhered crystals were washed away. The cells were subsequently treated for 5 to 10 minutes with 0.25% trypsin to digest cell surface glycoconjugates and thereby release most of the crystals attached to the cell exterior. TER measurements indicated that this mild enzyme treatment did not yet release the cells from each other or from the growth substrate. This method does not discriminate between crystals that are halfway through the membrane and those that are entirely inside the cell. With this restriction in mind, we considered the remaining cellassociated radiolabeled crystals as internalized.
RESULTS
Phase-contrast microscopy
The adherence of COM crystals to proliferating cells was viewed using light microscopy. These observations showed remarkable differences in the manner by which crystals were attached to LLC-PK 1 and MDCK-II compared to MDCK-I cells. The crystals appeared to be lying flat on the surface of the cell islands formed by LLC-PK 1 and MDCK-II. On the other hand, crystals were predominantly found at the periphery of the cell groups formed by MDCK-I (Fig. 1 ). These observations prompted us to inspect the attachment of crystals to these cell types more closely. 
Crystal binding
Hyaluronan (HA) is one of the major crystal-binding molecules at the surface of MDCK-I cells [9] . To determine whether HA also plays a role in crystal binding to LLC-PK 1 and MDCK-II, these cells were treated with Streptomyces hyaluronidase prior to incubating subconfluent cultures with radiolabeled COM crystals. Hyaluronidase significantly reduced the level of binding to MDCK-I cells, whereas this enzyme had no or negligible effect on crystal binding to LLC-PK 1 and MDCK-II cells (Fig. 1) .
Electron microscopy
Electron microscopy (EM) images were made to study the interaction between crystals and the different cell types more in detail. Scanning electron microscopy (SEM) images showed the attachment of COM crystals to the surface of MDCK-II cells (Fig. 2) that is abundantly covered with microvilli (Fig. 2) . Figure 2 suggests that the crystals became embedded in the plasma membrane and even entered the cells. Similar results were obtained with LLC-PK 1 (not shown). SEM images of crystal binding to MDCK-I cells were entirely different, however. Although our standard [ 14 C]COM crystal-binding studies indicated that relatively large amounts of crystals were able to bind to proliferating MDCK-I, these crystals were hardly recovered in the SEM images. This suggests that these crystals are lost somewhere during preparation, a process that requires extensive washing steps. To assess if crystals actually entered certain cell types, the cells were incubated for two hours with COM crystals, after which single cell suspensions were prepared with trypsin to be inspected by transmission electron microscopy (TEM). These images indeed provided evidence for the presence of crystals inside MDCK-II cells in the form of so-called ghosts (Fig. 2) . Crystal ghosts were also seen in LLC-PK 1 cells but never inside MDCK-I cells (not shown).
Effect of fixatives and enzymes on the release of cell surface-associated [ 14 
C]COM
The presence in the SEM images of crystals at the surface of LLC-PK 1 and MDCK-II cells, and their absence from MDCK-I, as well as the adherence of crystals to these cells under phase-contrast microscopy, suggests that there are differences in the way by which crystals attach to these cell types. To test this concept, radiolabeled COM crystals were allowed to adhere to the various cell types, after which the cells were treated either with ethanol to dehydrate the cell surface or with formaldehyde/glutaraldehyde to cross-link membrane proteins. These treatments released relatively large amounts of crystals from MDCK-I. Ethanol had the most profound effect and liberated approximately 60% of the cell surface-associated [ 14 C]COM, whereas formaldehyde/glutaraldehyde released about 40% of adhered crystals. Neither fixation method, however, significantly liberated crystals from MDCK-II or LLC-PK 1 cells (Table 1) . 
Confocal microscopy
To assess the fate of cell surface-associated crystals, we performed time-lapse studies using confocal microscopy. Nonradiolabeled COM crystals were added to subconfluent cultures formed by the various cell lines. Confocal images made perpendicular to the cell surface showed that after half an hour at 37ЊC, crystals were exclusively located at the surface of all cell types. After 90, 180, and 300 minutes, however, crystals were found inside LLC-PK 1 and MDCK-II cells unless they were kept in the cold (300 minutes, 4ЊC), indicating that crystal uptake is an active process. It should be noted that crystals were also taken up by confluent LLC-PK 1 and MDCK-II cells, indicating that the uptake of crystals was not crucially dependent on their stage of development (not shown). In contrast, crystals were never found inside MDCK-I cells. Since MDCK-I cells form hyaluronanrich cell coats [3, 24] , it cannot be excluded that these coats make crystal internalization impossible by preventing the crystals from directly contacting the cell surface. Confocal images, however, revealed that crystals were also not taken up by cells that were made coat-free with hyaluronidase prior to the addition of crystals (not shown). To examine whether the inability to take up crystals could be an intrinsic property of late nephron cell types, crystal uptake was studied in RCCD 1 , another renal collecting duct cell line. The vast majority of the RCCD 1 cells also did not internalize COM crystals (Fig. 3) .
Quantification of crystal internalization
Experiments were performed to quantify crystal uptake. In time-lapse studies, radiolabeled COM crystals were allowed to interact with the cells. The cultures were subsequently briefly treated with trypsin to release crystals attached to the cell surface. The amount of MDCK-II-associated [ 14 C]COM that could not be released from the cells with trypsin gradually increased from background levels of 0.15 Ϯ 0.03 g/10 6 cells at 30 minutes to 3.85 Ϯ 0.04 g/10 6 cells after 300 minutes (Fig. 4) , indicating crystal internalization. Crystals were also taken up by LLC-PK 1 , but with a somewhat different time course. Uptake showed a steep rise from 0.88 Ϯ 0.11 to 3.23 Ϯ 0.21 g/10 6 cells between 30 and 90 minutes, followed by a slower increase to 4.70 Ϯ 0.77 g COM crystals per million LLC-PK 1 cells in the next hours. More than 90% of the [ 14 C]COM associated with MDCK-I was released by trypsin at all time points, and the amount of radiolabeled COM that remained associated with the cell surface after enzyme treatment never reached values above background (ϳ0.4 g/10 6 cells). We speculated that the polymer hyaluronan, the major binding substance at the surface of MDCK-I, might have prevented the crystals from contacting the membrane. To find out if the cell surface expression of hyaluronan is responsible for the inability of MDCK-I cells to take up crystals, uptake was measured by cells that were pretreated with hyaluronidase. The uptake assay demonstrated that crystals that were able to bind to MDCK-I after hyaluronidase treatment also did not enter the cells (not shown). [ 14 C]COM uptake studies performed with RCCD 1 cells showed that even after an incubation period of five hours at 37ЊC, more than 90% of the crystals associated with the cell surface could be removed with trypsin. In the time-lapse studies the amount of crystals internalized by RCCD 1 never exceeded background levels (Fig. 4) .
DISCUSSION
This study shows that the adherence of calcium oxalate monohydrate (COM) crystals to renal tubular cells is not necessarily followed by crystal uptake. Although crystals avidly bind to subconfluent LLC-PK 1 , MDCK-II, MDCK-I, and RCCD 1 cells, they are eagerly internalized by LLC-PK 1 and MDCK-II, but not by MDCK-I and RCCD 1 .
Light microscopy images showed that crystals entirely covered the surface of LLC-PK 1 and MDCK-II cells, whereas their adherence to MDCK-I cells seemed to be restricted to the cell periphery (Fig. 1) . Using radiolabeled COM it was demonstrated that, once attached to the surface of LLC-PK 1 or MDCK-II, only few crystals are liberated by fixation methods such as dehydration or protein crosslinking (Table 1) . Moreover, brief treatment with trypsin did not liberate many of the crystals attached to these two cell types. Hence, COM crystals became firmly anchored to the surface of LLC-PK 1 and MDCK-II cells. Electron microscopy images showed that crystals indeed became tightly embedded in the plasma membrane to ultimately end up inside these cells (Fig. 2) . These observations were confirmed by a [ 14 C]COM uptake assay, showing that the internalization of crystals by LLC-PK 1 and MDCK-II cells is temperature-and timedependent (Fig. 4) . Previously, we identified the polysaccharide hyaluronan (HA) as an important crystalbinding molecule at the surface of MDCK-I cells [9] . However, pretreatment of LLC-PK 1 and MDCK-II cells with hyaluronidase did not affect the affinity of these cell types for crystals, indicating that this form of binding does not depend on HA (Fig. 1) . Crystals became only loosely attached to MDCK-I cells. Fixation or short trypsin treatment liberated most of the crystals bound to these cells. The affinity of MDCK-I cells for COM crystals is significantly reduced after pretreatment with hyaluronidase [9] . The quantitative uptake assay confirmed that MDCK-I cells are unable to internalize COM crystals. The possibility that uptake is impeded by HA coats was canceled out by the observation that crystals also did not enter MDCK-I cells that were treated with hyaluronidase prior to the addition of crystals (not shown). COM crystals also were not taken up by RCCD 1 cells. Although an occasional RCCD 1 cell contained a crystal, the quantitative uptake assay clearly demonstrated that the COM crystal uptake by RCCD 1 cells is negligible. Collectively, these data show that crystals are taken up by LLC-PK 1 and MDCK-II, but not by MDCK-I and RCCD 1 .
LLC-PK 1 and MDCK-II cells exhibit many characteristics of the renal proximal tubule. Confluent monolayers formed by these cells are leaky (Ͻ200 ⍀ · cm 2 ), are endowed with a luxurious brush border packed with tall microvilli, and their membranes express high levels of alkaline phosphatase (AP) and ␥-glutamyltranspeptidase (␥-GT) activity [10] . In addition, LLC-PK 1 cells actively transport essential nutrients and water across the epithelium [14] . MDCK-I and RCCD 1 cells, on the other hand, resemble the renal collecting ducts in many respects. MDCK-I cells, isolated from the original MDCK cell line, develop a high transepithelial electrical resistance (Ͼ10,000 ⍀ · cm 2 ), are covered with short and stubby microvilli and express low levels of AP and ␥-GT [10] . MDCK-I exhibits significant carbonic anhydrase activity [15] and its inward current can be activated by vasoactive intestinal polypeptide [16] . RCCD 1 cells are isolated from rat collecting ducts; this cell line is also characterized by high transepithelial resistances (Ͼ3000 ⍀ · cm 2 ) and specific hormonal sensitivities. Their morphologic appearance resembles that of intact cortical collecting duct (CCD) [12] . On the basis of these results it is speculated that the ability of renal tubular cells to internalize crystals depends upon their segmental origin.
Up until now, crystal uptake studies have been predominantly performed with cells resembling the renal proximal tubule. Lieske et al [17] , for example, observed that African green monkey BSC-1 or parental MDCK (ATCC) cells rapidly took up calcium oxalate crystals. However, little is known about the segmental origin of BSC-1, whereas the original MDCK cell line contains various cell types, including proximal tubular cells [12] . Crystal uptake has been further studied in the proximal tubular opossum kidney cell line, OK-1 [18] , and again by several investigators in the original MDCK cell line [19] [20] [21] . Thus, these results are in agreement with those obtained with LLC-PK 1 and MDCK-II in the present study.
In vivo, the uptake of crystals followed by their translocation to the renal interstitium is typical for animals fed a stone-inducing diet, or for primary human forms of chronic hyperoxaluria [6, 22, 23] . In rats, hyperoxaluria is commonly generated by the addition of oxalate precursors such as ethylene glycol to the drinking water. Stoneinducing or, rather, crystal-inducing diets usually aim at increasing the amount of oxalate that is filtered at the glomerulus, thereby resembling primary forms of hyperoxaluria rather than idiopathic forms of calcium oxalate nephrolithiasis. High oxalate in ultrafiltrate may already lead to the formation of crystals in the proximal tubule and thus inevitably to crystal binding and uptake. Following this train of thought, it is reasonable to assume that evolution provided those areas of the urinary tract in which the urine can be very concentrated with a crystalrepulsive epithelial lining. Previously, we found that an intact monolayer formed by late nephron MDCK-I cells indeed is nonadherent to COM crystals. These anti-adherence properties were temporarily lost, however, during the healing of wounds made in confluent monolayers [24] . Evidence was provided that during tissue repair and remodeling, crystals adhered to the HA-rich zones surrounding the wounded areas [9] . From these observations it was speculated that crystal binding in late segments of the nephron and remaining part of the urinary tract requires some form of tissue damage [25, 26] .
During the concentration process in the kidney, oxalate gradually increases from, on average, 2 mol/L in ultrafiltrate to approximately 300 mol/L in the final urine. Oxalate is poorly soluble in the tubular fluid and calcium oxalate crystals are occasionally formed in anyone's kidneys. Although it is difficult to exactly pinpoint the segment in the nephron where crystal formation takes place, it is assumed to occur somewhere beyond the thin limbs [27] [28] [29] . Hence, proximal tubular cells are not used to encounter crystals, which might explain why this epithelium is not provided with an anti-adherent surface. However, the concentration of oxalate can be 10 to 20 times higher in plasma of patients suffering from inborn errors of oxalate metabolism [30] . Because the upper limits of supersaturation in the primary urine depend on the amount of oxalate that is filtered at the glomerulus, it is plausible that crystals are formed earlier in the nephrons of these patients. This implies that, in primary hyperoxaluria, crystals are formed at sites in the nephron where the epithelium is not protected against their adherence.
The essence of the present study is not the observation that crystals adhere to HA or to other cell surface constituents, but that certain cell types constitutively bind and take up crystals, whereas others do not. The possibility that crystal binding and uptake cannot be avoided in proximal tubules and that epithelial injury-induced binding in the collecting ducts does not involve crystal uptake may have consequences for the treatment of the various forms of renal stone disease. In patients suffering from primary forms of hyperoxaluria, measures should be taken to avoid crystal adherence in the proximal tubule, whereas in idiopathic recurrent calcium oxalate renal stone disease, the best approach could be the prevention of tissue damage in the distal tubule and/or collecting ducts.
